|
1
|
Rezazadeh M, Agah S, Kamyabi A, Akbari A,
Ghamkhari Pisheh R, Eshraghi A, Babakhani A, Ahmadi A, Paseban M,
Heidari P, et al: Effect of diabetes mellitus type 2 and
sulfonylurea on colorectal cancer development: A Case-control
study. BMC Gastroenterol. 24:3822024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mozooni Z, Golestani N, Bahadorizadeh L,
Yarmohammadi R, Jabalameli M and Amiri BS: The role of
interferon-gamma and its receptors in gastrointestinal cancers.
Pathol Res Pract. 248:1546362023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Y, Han Z, Li X, Huang A, Shi J and Gu
J: Epidemiology and risk factors of colorectal cancer in China.
Chin J Cancer Res. 32:729–741. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Benson AB III, Venook AP, Cederquist L,
Chan E, Chen YJ, Cooper HS, Deming D, Engstrom PF, Enzinger PC,
Fichera A, et al: Colon cancer, version 1.2017, NCCN clinical
practice guidelines in oncology. J Natl Compr Canc Netw.
15:370–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burzinskis E, Janulaityte I, Jievaltas M,
Skaudickas D, Burzinskiene G, Dainius E, Naudziunas A and
Vitkauskiene A: Inflammatory markers in prostate cancer: Potential
roles in risk stratification and immune profiling. J Immunotoxicol.
22:24977762025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tan J, Wu Z, Liu Y, Wang W, Qin W, Pan G,
Xiong Y, Ma J, Zhao J, Zhou H, et al: Transcriptional profiling
reveals H.pylori-associated genes induced inflammatory cell
infiltration and chemoresistance in gastric cancer. Front Immunol.
16:15925582025. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yuan S, Zhu L, Chen X and Lin Q: Huanglian
Jiedu Tang regulates the inflammatory microenvironment to alleviate
the progression of breast cancer by inhibiting the RhoA/ROCK
pathway. Tissue Cell. 95:1028502025. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim JY, Jung EJ, Kim JM, Lee HS, Kwag SJ,
Park JH, Park T, Jeong SH, Jeong CY and Ju YT: Dynamic changes of
neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio
predicts breast cancer prognosis. BMC Cancer. 20:12062020.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang XZ, Chen WJ, Zhang X, Wu CC, Zhang
CY, Sun SS and Wu J: An Elevated Platelet-to-Lymphocyte ratio
predicts poor prognosis and clinicopathological characteristics in
patients with colorectal cancer: A Meta-analysis. Dis Markers.
2017:10531252017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nøst TH, Alcala K, Urbarova I, Byrne KS,
Guida F, Sandanger TM and Johansson M: Systemic inflammation
markers and cancer incidence in the UK Biobank. Eur J Epidemiol.
36:841–848. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li X, Wu Q, Kong Y and Lu C: Mild
cognitive impairment in type 2 diabetes is associated with
fibrinogen-to-albumin ratios. PeerJ. 11:e158262023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu X, Sun T, Zhang X, Wang W, Ji Y and
Jing J: The predicting role of albumin to derived
neutrophil-to-lymphocyte ratio for the prognosis of esophageal
squamous cell carcinoma patients aged 60 years and above. BMC
Cancer. 25:6522025. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Poenariu IS, Boldeanu L, Ungureanu BS,
Caragea DC, Cristea OM, Pădureanu V, Siloși I, Ungureanu AM, Statie
RC, Ciobanu AE, et al: Interrelation of Hypoxia-inducible factor-1
Alpha (HIF-1 α) and the ratio between the mean corpuscular
Volume/Lymphocytes (MCVL) and the cumulative inflammatory index
(IIC) in ulcerative colitis. Biomedicines. 11:31372023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang J, Gong L, Zhu X, Wang Y and Li C:
Mediation of systemic inflammation response index in the
association of healthy eating Index-2020 in patientis with
periodontitis. Oral Health Prev Dent. 23:225–232. 2025.PubMed/NCBI
|
|
16
|
Wang Y, Lyu J, Jia H, Liang L, Xiao L, Liu
Y, Liu X, Li K, Chen T, Zhang R, et al: Clinical utility of the
systemic immune-inflammation index for predicting survival in
esophageal squamous cell carcinoma after radical radiotherapy.
Future Oncol. 17:2647–2657. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li H, Sun W, Fu S, Wang J, Jin B, Zhang S,
Liu Y, Zhang Q and Wang H: Prognostic value of the preoperative
prognostic nutritional and systemic immunoinflammatory indexes in
patients with colorectal cancer. BMC Cancer. 25:4032025. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Șerban RE, Popescu DM, Boldeanu MV,
Florescu DN, Șerbănescu MS, Șandru V, Panaitescu-Damian A,
Forțofoiu D, Șerban RC, Gherghina FL and Vere CC: The diagnostic
and prognostic role of inflammatory markers, including the new
cumulative inflammatory index (IIC) and mean corpuscular
volume/lymphocyte (MCVL), in colorectal adenocarcinoma. Cancers
(Basel). 17:9902025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xie H, Wei L, Liu M, Liang Y, Yuan G, Gao
S, Wang Q, Lin X, Tang S and Gan J: Prognostic significance of
preoperative prognostic immune and nutritional index in patients
with stage I–III colorectal cancer. BMC Cancer. 22:13162022.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong J, Jiang W, Zhang W, Guo T, Yang Y,
Jiang X, Zheng L and Du T: Exploring the J-shaped relationship
between HALP score and mortality in cancer patients: A NHANES
1999–2018 cohort study. Front Oncol. 14:13886102024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li K, Zeng X, Zhang Z, Wang K, Pan Y, Wu
Z, Chen Y and Zhao Z: Pan-immune-inflammatory values predict
survival in patients after radical surgery for non-metastatic
colorectal cancer: A retrospective study. Oncol Lett. 29:1972025.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iida H, Tani M, Komeda K, Nomi T,
Matsushima H, Tanaka S, Ueno M, Nakai T, Maehira H, Mori H, et al:
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a
non-invasive prognostic biomarker after hepatectomy for
hepatocellular carcinoma. HPB (Oxford). 24:101–115. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakashima K, Haruki K, Kamada T, Takahashi
J, Tsunematsu M, Ohdaira H, Furukawa K, Suzuki Y and Ikegami T:
Usefulness of the C-reactive protein (CRP)-Albumin-lymphocyte
(CALLY) index as a prognostic indicator for patients with gastric
cancer. Am Surg. 90:2703–2709. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fukushima N, Masuda T, Tsuboi K, Takahashi
K, Yuda M, Fujisaki M, Ikegami T, Yano F and Eto K: Prognostic
significance of the preoperative C-reactive
protein-albumin-lymphocyte (CALLY) index on outcomes after
gastrectomy for gastric cancer. Surg Today. 54:943–952. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Toda M, Musha H, Suzuki T, Nomura T and
Motoi F: Impact of C-reactive protein-albumin-lymphocyte index as a
prognostic marker for the patients with undergoing gastric cancer
surgery. Front Nutr. 12:15560622025. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Amin MB, Edge SB and Greene FL: AJCC
Cancer Staging Manual. 8th edition. New York: Springer; 2016
|
|
27
|
Grivennikov S, Karin E, Terzic J, Mucida
D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H,
Eckmann L and Karin M: IL-6 and Stat3 are required for survival of
intestinal epithelial cells and development of colitis-associated
cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Binnewies M, Roberts EW, Kersten K, Chan
V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI,
Ostrand-Rosenberg S, Hedrick CC, et al: Understanding the tumor
immune microenvironment (TIME) for effective therapy. Nat Med.
24:541–550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mima K, Nishihara R, Qian ZR, Cao Y,
Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, et al:
Fusobacterium nucleatum in colorectal carcinoma tissue and
patient prognosis. Gut. 65:1973–1980. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen WD, Zhang X, Zhang YP, Yue CB, Wang
YL, Pan HW, Zhang YL, Liu H and Zhang Y: Fusobacterium
nucleatum is a risk factor for metastatic colorectal cancer.
Curr Med Sci. 42:538–547. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tauriello DVF, Palomo-Ponce S, Stork D,
Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M,
Ibiza S, Cañellas A, Hernando-Momblona X, et al: TGFβ drives immune
evasion in genetically reconstituted colon cancer metastasis.
Nature. 554:538–543. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang A, Wu Y, Cui J, Cai M, Xie Y, Zou J,
Alenzi M, Yang H, Huang P and Huang M: Assessment of
compartment-specific CD103-positive cells for prognosis prediction
of colorectal cancer. Cancer Immunol Immunother. 74:2372025.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hashimoto I, Tanabe M, Onuma S, Morita J,
Nagasawa S, Maezawa Y, Kanematsu K, Aoyama T, Yamada T, Yukawa N,
et al: Clinical impact of the C-reactive Protein-albumin-lymphocyte
index in Post-gastrectomy patients with gastric cancer. In Vivo.
38:911–916. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and
Schreiber RD: Cancer immunoediting: From immunosurveillance to
tumor escape. Nat Immunol. 3:991–998. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Łuksza M, Sethna ZM, Rojas LA, Lihm J,
Bravi B, Elhanati Y, Soares K, Amisaki M and Dobrin A: Neoantigen
quality predicts immunoediting in survivors of pancreatic cancer.
Nature. 606:389–395. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reina-Campos M, Heeg M, Kennewick K,
Mathews IT, Galletti G, Luna V, Nguyen Q, Huang H, Milner JJ, Hu
KH, et al: Metabolic programs of T cell tissue residency empower
tumour immunity. Nature. 621:179–187. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Furukawa S, Hiraki M, Kimura N, Sakai M,
Ikubo A and Samejima R: The potential of the C-reactive
protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker
in colorectal cancer. Cancer Diagn Progn. 5:370–377. 2025.
View Article : Google Scholar : PubMed/NCBI
|
